Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) EBIT Margin (2023 - 2025)

Historic EBIT Margin for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to 0.78%.

  • BioScience Health Innovations' EBIT Margin fell 105900.0% to 0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.74%, marking a year-over-year increase of 162300.0%. This contributed to the annual value of 4.72% for FY2024, which is 468000.0% up from last year.
  • Per BioScience Health Innovations' latest filing, its EBIT Margin stood at 0.78% for Q3 2025, which was down 105900.0% from 26.04% recorded in Q2 2025.
  • In the past 5 years, BioScience Health Innovations' EBIT Margin ranged from a high of 34.78% in Q1 2025 and a low of 218.68% during Q1 2023
  • For the 3-year period, BioScience Health Innovations' EBIT Margin averaged around 28.38%, with its median value being 0.78% (2025).
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 1994600bps in 2024, then tumbled by -105900bps in 2025.
  • Over the past 3 years, BioScience Health Innovations' EBIT Margin (Quarter) stood at 12.64% in 2023, then skyrocketed by 113bps to 1.63% in 2024, then crashed by -148bps to 0.78% in 2025.
  • Its EBIT Margin was 0.78% in Q3 2025, compared to 26.04% in Q2 2025 and 34.78% in Q1 2025.